2012
DOI: 10.3126/jpn.v2i4.6881
|View full text |Cite
|
Sign up to set email alerts
|

Value of Calcium and Phosphorous in chronic kidney disease patients under hemodialysis: A retrospective study

Abstract: Background: Derangements of mineral metabolism occur during early stages of chronic kidney disease (CKD). Mineral metabolism has emerged as important predictors of morbidity and mortality in dialysis patients. This study aims to evaluate the values of calcium and phosphorous in reference to practice guidelines issued by National Kidney Foundation Dialysis Outcomes Quality Initiative (K/DOQI) in patients undergoing hemodialysis in KIST Medical College Teaching Hospital.Materials and Methods: It was a retrospect… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
4
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 15 publications
3
4
0
Order By: Relevance
“…hyperphosphatemia in CKD patients Hyperphosphatemia is one of the major factors liable for alterations in mineral and bone metabolism in dialysis patients. These findings are similar to the study done in Iran through Mahdavi-Mazdeh M et al 17 and Singh S et al 13 in Nepal. Hyperphosphatemia results due to reduced phosphorous filtration and excretion with the progression of CKD.…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…hyperphosphatemia in CKD patients Hyperphosphatemia is one of the major factors liable for alterations in mineral and bone metabolism in dialysis patients. These findings are similar to the study done in Iran through Mahdavi-Mazdeh M et al 17 and Singh S et al 13 in Nepal. Hyperphosphatemia results due to reduced phosphorous filtration and excretion with the progression of CKD.…”
Section: Discussionsupporting
confidence: 92%
“…So, mineral metabolism results are gaining significance in hemodialysis treatment. 13 In our study, the mean serum calcium in CKD subjects was 8.03±0.80 and in controls was 9.06±0.54 with p value < 0.001 which was statistically significant. Majority of our study subjects were hypocalcemic.…”
Section: Discussionsupporting
confidence: 49%
“…16 Abnormal mineral metabolism starts early in the course of CKD and ESRD, and is usually accompanied by profound changes such as bone disease, musculoskeletal symptoms and growth retardation. 17 The pathophysiology of both idiopathic and secondary RLS is still a subject of discussion. A limited number of studies have been conducted to find out the pathophysiology of RLS in uremic patients.…”
Section: Discussionmentioning
confidence: 99%
“…The disturbances embrace calcium, phosphorous, vitamin D, and PTH homeostasis. So, mineral metabolism results are gaining significance in hemodialysis treatment (Singh S. et al 2012). On the other hand, similar results to ours are mentioned in other studies from RusulArif 2018 and Freethi et al 2016, where significant hypocalcemia is observed in CKD patients.…”
Section: Figure 2 Etiology Of Chronic Kidney Diseasementioning
confidence: 99%